Compare COR & MFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COR | MFC |
|---|---|---|
| Founded | 2001 | 1887 |
| Country | United States | Canada |
| Employees | N/A | 37000 |
| Industry | Other Pharmaceuticals | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.5B | 56.6B |
| IPO Year | 2001 | N/A |
| Metric | COR | MFC |
|---|---|---|
| Price | $305.80 | $39.26 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 1 |
| Target Price | ★ $390.62 | $52.00 |
| AVG Volume (30 Days) | 1.2M | ★ 1.5M |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | 0.77% | ★ 3.40% |
| EPS Growth | ★ 5.71 | N/A |
| EPS | ★ 2.87 | N/A |
| Revenue | ★ $321,332,819,000.00 | N/A |
| Revenue This Year | $8.89 | $40.66 |
| Revenue Next Year | $6.75 | $6.23 |
| P/E Ratio | $107.08 | ★ $16.52 |
| Revenue Growth | ★ 9.31 | N/A |
| 52 Week Low | $273.43 | $29.70 |
| 52 Week High | $377.54 | $39.33 |
| Indicator | COR | MFC |
|---|---|---|
| Relative Strength Index (RSI) | 35.49 | 68.22 |
| Support Level | $296.08 | $35.99 |
| Resistance Level | $306.90 | N/A |
| Average True Range (ATR) | 7.04 | 0.61 |
| MACD | -0.11 | 0.02 |
| Stochastic Oscillator | 17.07 | 77.50 |
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Manulife Financial is one of the Big Three Canadian life insurers. The firm provides life insurance, annuities, asset management, and wealth management products to individuals and group customers in Canada, the United States, and Asia. The Canadian business segment contributes approximately 21% of 2025 adjusted earnings. The Asia segment operates across 12 countries and contributes around 38% of earnings, with a significant presence in Hong Kong and Singapore. The US business, which primarily operates under the John Hancock brand, contributes about 16% of earnings. Manulife's global asset and wealth management business contributes approximately 25% of its earnings and had around CAD 1.1 trillion in assets under management and administration as of the end of 2025.